ATE474561T1 - Orodispersible pharmazeutische zusammensetzung für die orale, oromukosale oder sublinguale verabreichung von agomelatin - Google Patents

Orodispersible pharmazeutische zusammensetzung für die orale, oromukosale oder sublinguale verabreichung von agomelatin

Info

Publication number
ATE474561T1
ATE474561T1 AT06291919T AT06291919T ATE474561T1 AT E474561 T1 ATE474561 T1 AT E474561T1 AT 06291919 T AT06291919 T AT 06291919T AT 06291919 T AT06291919 T AT 06291919T AT E474561 T1 ATE474561 T1 AT E474561T1
Authority
AT
Austria
Prior art keywords
agomelatin
oromucosal
oral
pharmaceutical composition
sublingual administration
Prior art date
Application number
AT06291919T
Other languages
English (en)
Inventor
Marc Julien
Francois Tharrault
Jean-Manuel Pean
Patrick Wuthrich
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36663148&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE474561(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of ATE474561T1 publication Critical patent/ATE474561T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06291919T 2005-12-14 2006-12-14 Orodispersible pharmazeutische zusammensetzung für die orale, oromukosale oder sublinguale verabreichung von agomelatin ATE474561T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0512647A FR2894475B1 (fr) 2005-12-14 2005-12-14 Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine

Publications (1)

Publication Number Publication Date
ATE474561T1 true ATE474561T1 (de) 2010-08-15

Family

ID=36663148

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06291919T ATE474561T1 (de) 2005-12-14 2006-12-14 Orodispersible pharmazeutische zusammensetzung für die orale, oromukosale oder sublinguale verabreichung von agomelatin

Country Status (40)

Country Link
US (1) US7892575B2 (de)
EP (1) EP1800669B1 (de)
JP (2) JP4996225B2 (de)
KR (3) KR20070063420A (de)
CN (2) CN1981752B (de)
AP (1) AP2714A (de)
AR (1) AR058332A1 (de)
AT (1) ATE474561T1 (de)
AU (1) AU2006252051B2 (de)
BR (1) BRPI0605214A (de)
CA (1) CA2571202C (de)
CO (1) CO5770094A1 (de)
CR (1) CR8788A (de)
CU (1) CU23603B7 (de)
CY (1) CY1110824T1 (de)
DE (1) DE602006015592D1 (de)
DK (1) DK1800669T3 (de)
EA (1) EA013751B1 (de)
ES (1) ES2348994T3 (de)
FR (1) FR2894475B1 (de)
GE (1) GEP20084509B (de)
GT (1) GT200600500A (de)
HN (1) HN2008000874A (de)
HR (1) HRP20100517T1 (de)
IL (1) IL180036A0 (de)
MA (1) MA28722B1 (de)
MX (1) MXPA06014605A (de)
MY (1) MY143221A (de)
NO (1) NO20065701L (de)
NZ (1) NZ552025A (de)
PE (1) PE20071030A1 (de)
PL (1) PL1800669T3 (de)
PT (1) PT1800669E (de)
RS (1) RS51452B (de)
SG (1) SG133531A1 (de)
SI (1) SI1800669T1 (de)
TW (1) TWI327911B (de)
UA (1) UA86622C2 (de)
WO (1) WO2007068829A1 (de)
ZA (1) ZA200610511B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080031927A1 (en) * 2006-07-11 2008-02-07 Catani Steven J Solid oral dosage vitamin and mineral compositions
PT2238974E (pt) 2009-04-09 2013-07-09 E Pharma Trento Spa Granulado para a formulação de comprimidos orodispersíveis
CN101781226B (zh) 2009-12-23 2012-03-28 天津泰普药品科技发展有限公司 阿戈美拉汀及其药物组合物
WO2011111027A2 (en) 2010-03-11 2011-09-15 Dexcel Pharma Technologies Ltd. Oral dispersible delayed release tablet formulation
CN101836966A (zh) * 2010-05-27 2010-09-22 北京万全阳光医药科技有限公司 一种含有阿戈美拉汀的口腔崩解片
CN101991559B (zh) * 2010-11-25 2012-04-18 天津市汉康医药生物技术有限公司 一种稳定的阿戈美拉汀胶囊药物组合物
US8426461B2 (en) 2011-01-17 2013-04-23 Takeda Pharmaceutical Company Limited Orally dispersible tablet
JP5600747B2 (ja) 2011-01-17 2014-10-01 武田薬品工業株式会社 口腔内分散性製剤
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
EP2765985A1 (de) 2011-10-14 2014-08-20 Takeda Pharmaceutical Company Limited In der mundhöhle dispergierbare tablette
CN103169669B (zh) * 2011-12-26 2015-06-17 中国人民解放军军事医学科学院毒物药物研究所 阿戈美拉汀包衣微丸以及可在口中分散的药物组合物
CN102552211B (zh) * 2012-02-16 2013-07-17 福建广生堂药业股份有限公司 一种阿戈美拉汀的制剂组合物及其制备方法
FR3000896B1 (fr) * 2013-01-14 2016-08-26 Philippe Perovitch Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil
FR3001894A1 (fr) 2013-02-08 2014-08-15 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
HUE036989T2 (hu) * 2013-06-06 2018-08-28 Zentiva Ks Agomelatin készítmény, amely agomelatint ko-kristály formájában tartalmaz
EP2810647A1 (de) 2013-06-06 2014-12-10 Zentiva, a.s. Pharmazeutische Formulierungen, enthaltend Agomelatin in der Form des Co-Kristalls von Agomelatin mit organischer Säure
CA2888219C (en) * 2014-02-07 2018-07-10 Scilabs Pharmaceuticals, Inc. All natural, non-toxic sublingual drug delivery systems
CN104523639B (zh) * 2014-12-11 2017-03-22 扬子江药业集团四川海蓉药业有限公司 一种阿戈美拉汀片剂及其制备方法
EP4378527A3 (de) * 2019-12-20 2024-09-11 LTS Lohmann Therapie-Systeme AG Transmukosales therapeutisches system mit agomelatin
ES3003263T3 (en) * 2019-12-20 2025-03-10 Lts Lohmann Therapie Systeme Ag Transmucosal therapeutic system containing agomelatine
NL2031331B1 (en) 2022-03-18 2023-09-29 Plethora Therapeutics B V Transmucosal delivery of a short-acting psychedelic compound
NL2031332B1 (en) 2022-03-18 2023-09-29 Plethora Therapeutics B V Transmucosal delivery of psychoactive compounds
CN117562862A (zh) * 2023-08-29 2024-02-20 宝利化（南京）制药有限公司 一种阿戈美拉汀的固体药物组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5762963A (en) * 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
EP1175899B1 (de) * 2000-07-27 2007-08-29 Roquette FrÀ¨res Granulat bestehend aus Stärke und Laktose
JP2002338500A (ja) * 2001-03-15 2002-11-27 Yamanouchi Pharmaceut Co Ltd 苦味を低減した口腔内速崩壊錠および苦み低減化方法
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine

Also Published As

Publication number Publication date
ES2348994T3 (es) 2010-12-21
NO20065701L (no) 2007-06-15
AP2006003844A0 (en) 2006-12-31
EA013751B1 (ru) 2010-06-30
CA2571202A1 (fr) 2007-06-14
CN1981752B (zh) 2011-11-02
HN2008000874A (es) 2012-02-27
CU23603B7 (es) 2010-12-08
KR20080108068A (ko) 2008-12-11
BRPI0605214A (pt) 2007-10-09
WO2007068829A1 (fr) 2007-06-21
PT1800669E (pt) 2010-08-17
HK1101802A1 (en) 2007-10-26
AP2714A (en) 2013-07-31
US7892575B2 (en) 2011-02-22
JP4996225B2 (ja) 2012-08-08
KR101013667B1 (ko) 2011-02-10
KR20070063420A (ko) 2007-06-19
EA200602104A1 (ru) 2007-06-29
EP1800669A1 (de) 2007-06-27
JP2012092132A (ja) 2012-05-17
HRP20100517T1 (hr) 2010-10-31
NZ552025A (en) 2008-12-24
JP2007182440A (ja) 2007-07-19
EP1800669B1 (de) 2010-07-21
CO5770094A1 (es) 2007-06-29
US20070134331A1 (en) 2007-06-14
TW200738230A (en) 2007-10-16
TWI327911B (en) 2010-08-01
AR058332A1 (es) 2008-01-30
UA86622C2 (ru) 2009-05-12
CY1110824T1 (el) 2015-06-10
AU2006252051A1 (en) 2007-06-28
FR2894475B1 (fr) 2008-05-16
SG133531A1 (en) 2007-07-30
DE602006015592D1 (de) 2010-09-02
FR2894475A1 (fr) 2007-06-15
MA28722B1 (fr) 2007-07-02
GEP20084509B (en) 2008-10-10
KR20100012858A (ko) 2010-02-08
SI1800669T1 (sl) 2010-11-30
DK1800669T3 (da) 2010-10-25
GT200600500A (es) 2007-07-25
ZA200610511B (en) 2008-05-28
CR8788A (es) 2008-08-21
MXPA06014605A (es) 2009-02-11
PL1800669T3 (pl) 2010-12-31
MY143221A (en) 2011-03-31
CN1981752A (zh) 2007-06-20
AU2006252051B2 (en) 2013-03-14
PE20071030A1 (es) 2007-11-17
CA2571202C (fr) 2012-01-10
CU20060243A7 (es) 2009-09-08
IL180036A0 (en) 2008-01-20
RS51452B (sr) 2011-04-30
CN101919800A (zh) 2010-12-22

Similar Documents

Publication Publication Date Title
DE602006015592D1 (de) Orodispersible pharmazeutische Zusammensetzung für die orale, oromukosale oder sublinguale Verabreichung von Agomelatin
FR2892937B1 (fr) Forme pharmaceutique orale microparticulaire anti-mesusage
BRPI0511900A (pt) composições farmacêuticas
DE602004011398D1 (de) Direkt komprimierbare pharmazeutische zusammensetzung für die orale verabreichung von cci-779
RU2398586C3 (ru) Фармацевтическая композиция
EP1922025A4 (de) Arzeinmittelfreisetzendes implantat
DK1474152T3 (da) Orodispergerbar farmaceutisk sammensætning omfattende ivabradin
NO20043473L (no) Orodispersibel farmasoytisk sammensetning omfattende perindopril
EP1900368A4 (de) Tablette mit einem kaum löslichen wirkstoff
FI20077133L (fi) Essitalopraamin kiteinen emäs ja essitalopraamiemästä sisältäviä, suussa hajoavia tabletteja
ITFI20080016A1 (it) Formulazioni farmaceutiche orali contenenti gliclazide.
BRPI0815562A2 (pt) Soluções farmacêuticas orais contendo telbivudina.
NO20064808L (no) Orale matrixformuleringer med licarbazepin
EP1714648A4 (de) Kombinationsarzneimittel
DK1784174T3 (da) Famaceutisk sammensætning omfattende gabapentin
BRPI0614413A2 (pt) composto, e, composição farmacêutica
BRPI0614412A2 (pt) composto, e, composição farmacêutica
ITMI20040943A1 (it) Composizione farmaceutica cicatrizzante
ATE489943T1 (de) Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivate
EA200800733A1 (ru) Фармацевтический хитозановый наполнитель для применения в твёрдых лекарственных формах
EP1747205A4 (de) Pharmazeutische zusammensetzungen
EP1556022A4 (de) WûSSRIGE PHARMAZEUTISCHE 2,6-DIISOPROPYLPHENOL-ZUSAMMENSETZUNGEN
ATE416166T1 (de) Novel polysubstituted 1,1- pyridinylaminocyclopropanamine derivatives, processes for their preparation and pharmaceutical composition containing them
ITMI20021127A1 (it) Composizioni farmaceutiche oromucosali
ITMI20040621A1 (it) Composizioni farmaceutiche orali

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1800669

Country of ref document: EP